Hepatocyte Kctd17 Inhibition Ameliorates Glucose Intolerance and Hepatic Steatosis Caused by Obesity-induced Chrebp Stabilization

Oh, A.-R., Jeong, Y., Yu, J., Minh Tam, D. T., Kang, J. K., Jung, Y. H., Im, S.-S., Lee, S. B., Ryu, D., Pajvani, U. B., & Kim, K. (2023). Hepatocyte Kctd17 Inhibition Ameliorates Glucose Intolerance and Hepatic Steatosis Caused by Obesity-induced Chrebp Stabilization. Gastroenterology, 164(3), 439–453. https://doi.org/10.1053/j.gastro.2022.11.019
Authors:
Ah-Reum Oh
Yelin Jeong
Junjie Yu
Dao Thi Minh Tam
Jin Ku Kang
Young Hoon Jung
Seung-Soon Im
Sang Bae Lee
Dongryeol Ryu
Utpal B Pajvani
KyeongJin Kim
Affiliated Authors:
Junjie Yu
Jin Ku Kang
Utpal B Pajvani
Columbia Affiliation:
Subjects:
Non-alcoholic Fatty Liver Disease (MeSH)
Glucose Intolerance (MeSH)
Diabetes Mellitus, Type 2 (MeSH)
Insulin Resistance (MeSH)
Author Keywords:
chrebp
kctd17
nafld
type 2 diabetes
elink
Publication Type:
Article
Unique ID:
10.1053/j.gastro.2022.11.019
PMID:
36402191
DOI:
10.1053/j.gastro.2022.11.019
Journal:
Gastroenterology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: